Alejandro Perez-Verdia, MD

Alejandro Perez-Verdia, MD, is a fellowship-trained electrophysiologist with Saint Luke’s Cardiovascular Consultants. Passionate about teaching and research, Dr. Perez-Verdia has specialized training in treating atrial fibrillation, supra ventricular tachycardia (SVT), atrial flutter, and more. He is committed to excellent patient care and values building strong patient relationships.

1. Stetson SJ, Perez-Verdia A, Vatta M, Bowles NE, Towbin JA, Torre-Amione G. Improved myocardial structure following LVAD support: effect of unloading on dystrophin expression J Heart Lung Transplant. 2001;20(2):240
2. Nagueh SF, Stetson SJ, Lakkis NM, Killip D, Perez-Verdia A, Entman ML, Spencer WH 3rd, Torre-Amione G. Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy; Circulation 2001;103(14):1844-50
3. Bruckner BA, Stetson SJ, Perez-Verdia A, Youker KA, Radovancevic B, Connelly JH, Koerner MM, Entman ME, Frazier OH, Noon GP, Torre-Amione G. Regression of fibrosis and hypertrophy in failing myocardium following mechanical circulatory support. J Heart Lung Transplant 2001;20(4):457-64
4. Perez-Verdia A, Stetson SJ, McRee S, Mazur W, Koerner MM, Torre-Amione G. The effect of cytokines on cardiac allograft function: tumor necrosis factor alpha a mediator of chronic injury. Heart Failure Rev 2001;6(2):137-41
5. Stetson SJ, Perez-Verdia A, Mazur W, Farmer JA, Koerner MM, Weilbaecher DG, Entman ML, Quinones MA, Noon GP, Torre-Amione G. Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha.Circulation 2001;104(6):676-81
6. Vatta M, Stetson SJ, Perez-Verdia A, Entman ML, Noon GP, Torre-Amione G, Bowles NE, Towbin JA. Molecular remodeling of dystrophin in patients with end-stage cardiomyopathies and reversal in patients on assistance-device therapy Lancet 2002;359(9310):936-41
7. Mazur W, Rivera JM, Khoury AF, Basu AG, Perez-Verdia A, Marks GF, Chang SM, Olmos L, Quinones MA, Zoghbi WA. Prognostic value of exercise echocardiography: validation of a new risk index combining echocardiographic, treadmill, and exercise electrocardiographic parameters. J Am Soc Echocardiogr 2003;16(4):318-25 Sarria JC, Perez-Verdia A, Kimbrough RC 3rd, Vidal AM. Deep sternal wound infection caused by group g streptococcus after open-heart surgery. Am J Med Sci 2004;327(5):253-4
8. Perez-Verdia A, Angulo F, Hardwicke FL, Nugent KM. Acute cardiac toxicity associated with high-dose intravenous methotrexate therapy: case report and review of the literature. Pharmacotherapy 2005;25(9):1271-6
9. Kumar A, Jenkins LA, Perez-Verdia A, Roongsritong C. Transient left ventricular apical ballooning during dobutamine myocardial perfusion imaging Int. J. Cardiol. 2008 Mar 14; 124(3):378-80
10. Cevik C, Perez-Verdia A, Nugent K. Implantable cardioverter defibrillators and their role in heart failure progression; Europace. 2009;11(6):710-5
11. Yaqub Y, Suarez J, Perez-Verdia A, Arvandi A, Nugent KM. Klippel-Trenaunay syndrome and radial artery coronary graft spasm. J Coll Physicians Surg Pak 2009;19(10):658-60
12. Cevik C, Nugent K, Perez-Verdia A, Fish RD. Prophylactic implantation of cardioverter defibrillators in idiopathic nonischemic cardiomyopathy for the primary prevention of death: a narrative review. Clinical Cardiolgy 2010;33(5)254-60
13. Warangkana Chokesuwattanaskul M.D., Yasir Yaqub M.D., Jose A Suarez M.D., Jan Simoni PhD., Grace Simoni PhD., Kenneth M Nugent M.D., Rosalinda Jimenez RN, MSN, C- FNP. Alejandro Perez-Verdia M.D. Effect of Pioglitazone on platelet aggregation in a healthy cohort Cardiology 2010; 116(4)253-56
14. Yasir Yaqub MD, Alejandro Perez-Verdia MD, Leigh A. Jenkins MD, Robert L. Paige PhD, Kenneth M. Nugent MD; Temporary Transvenous Cardiac Pacing in Patients with Acute Myocardial Infarction Predicts Increased Mortality. Cardiology Research 2012;3(1) 1-7
15. Ragesh Panikkath, MD, Kenneth Nugent, MD, Alejandro Perez-Verdia, MD; Atrial fibrillation after inhalational lung injury- a troubling complication of a rare problem.; Case Reports in Medicine 2012;2012:302057 
16. Hall C, Velasco A, Raj R, Leiker M, Kumar A, Nugent K, Perez-Verdia A.; 610 Continuous Positive Airway Pressure (CPAP) May Reduce the Need For Permanent Pacemaker Implantation in Patients With Sinus Node Dysfunction and Obstructive Sleep Apnea. Canadian Journal of Cardiology 2012:28(5)Supplement S326
17. Abo-Salem E, Paone RF, Nugent K, Perez-Verdia A, Deshpande A, Amiri HM.; Stand alone surgical ablation for atrial fibrillation. Journal of Cardiac Surgery 2013:28(3):315-20 
18. Velasco A, Hall C, Perez-Verdia A, Nugent K.; Association of high-risk scores for obstructive sleep apnea with symptomatic bradyarrhythmias. Journal of Cardiovascular Medicine 2013 (Epub ahead of print) PMID: 23867909
19. Teerapat Nantsupawat, MD, Chikako Ono, MD, Elvira Umyarova, MD, Charoen Mankongpaisarnrung, MD, Ragesh Panikkath, MD, Aliakbar Arvandi, MD, Alejandro Verdia, MD, Tiffany Bunag, BA, Gary Meyerrose, MD; Effects of Alcohol and Illicit Substance Consumption in Patients with Infective Endocarditis. Alcoholism Treatment Quarterly 2013:31150-160
20. Abo-Salem E, Fowler JC, Attari M, Cox CD, Perez-Verdia A, Panikkath R, Nugent K.; Antibiotic-induced Cardiac Arrhythmias. Cardiovascular Therapeutics 2014:32(1):19-25
21. Colbert Perez MD, Alejandro Perez-Verdia MD; Atrial Fibrillation: Risk Assessment. Southwest Respiratory and Critical Care Chronicles 2014;2(6):52-55
22. Nantsupawat T, Soontrapa S, Nantsupawat N, Sotello D, Klomjit S, Adabag S, Perez-Verdia A.; Risk factors and prevention of dabigatran related gastrointestinal bleeding in patient with atrial fibrillation. Journal of Arrhythmia 2018;34(1):30-35